Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Lockheed, Northrop and BAE Slide as the Democratic Sweep Clouds Trump’s $1.5 Trillion Defense Budget, With Europe’s Defense Basket Down as Much as 4.1%

by Team Lumida
November 4, 2026
in Equities
Reading Time: 4 mins read
A A
0
Lockheed Martin $LMT Q2 2024 Results
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • Defense bucked the rally. Lockheed Martin and Northrop Grumman fell more than 3% before the opening bell on Wednesday, Bloomberg reported, and in morning trading Lockheed and L3Harris were down more than 5% while Northrop and RTX fell around 4%, according to the FT. Palantir, whose software is widely used by military and police forces, was 4.7% lower before the open.
  • Europe followed. A Goldman Sachs basket of Europe’s defense firms fell as much as 4.1%, its steepest drop in more than four months, and the UK’s BAE Systems, which gets nearly half its revenue from the US, declined as much as 5.9%. Mwb Research’s Jens-Peter Rieck said the result removes the “US walks away from Europe scare” that drove the sector’s 2025 rally.
  • The budget is now in question. Trump had called for $1.5 trillion in defense spending for the fiscal year ending in 2027, up from $1 trillion, according to the FT. TD Cowen’s Roman Schweizer called a Democratic sweep “clearly the toughest outcome for defense spending” and expects the next Congress to vote to compel Trump to end the war in Iran, saying it is now “more conceivable” enough Republicans join to override a veto.
  • Not everyone is selling. “The bulk of the defense budget is set in stone,” said Siebert Financial’s Mark Malek, arguing missile replenishment and next-generation defense tech have broad support. Mediobanca’s Alessandro Pozzi pointed to bipartisan backing for air and missile defense, the Golden Dome and shipbuilding, though funding remains subject to political debate.

What Happened?

Defense stocks on both sides of the Atlantic slid as the Democrats’ landslide in the midterm elections dented expectations of a further ramp-up in US military spending, even as the broader US market rallied. The sector had been riding high into 2026 on geopolitical tensions and government plans to boost defense budgets, but it has been volatile as investors braced for a Democratic win that could bring tighter oversight and funding delays. “There are now some more open questions about the path forward for the defense budget,” said Truist Advisory Solutions CIO Keith Lerner. Relations between Defense Secretary Pete Hegseth and Congress have soured over the Iran war, and Democrats have vowed to reverse deep cuts to domestic programs, the FT reported.

Why It Matters?

Prime contractors depend heavily on US government spending, so a shift in Congress hits their growth outlook directly, while Trump’s comments that he has no immediate plans to strike Iran and more dovish talk on a peace settlement point to less urgency for emergency spending. TD Cowen warned the impact “could go well beyond spending and impact national security and foreign policy.” The selloff also shows how much of the sector’s premium was built on the $1.5 trillion budget proposal. Some investors had bought volatility in US defense names ahead of the vote, betting Democrats would still back munitions replenishment after the Iran war depleted stockpiles, which could limit how far the selloff runs.

What’s Next?

The lame-duck session before the new Congress is seated “becomes very important very quickly,” Schweizer said, as members work to pass a baseline defense budget and additional funds through a fast-track measure. RBC Capital Markets’ Ken Herbert said the biggest near-term concern is whether Democrats will back a large supplemental spending bill to cover the costs of the Iran conflict. In Europe, Hensoldt, Rheinmetall and Renk report third-quarter results on Thursday, which Rieck said could bring bigger moves.

Affected Tickers and Coins: LMT, NOC, LHX, RTX, PLTR, ITA

Source: Bloomberg, Financial Times

Previous Post

ISM Services Index Slips to 54.5, a Three-Month Low, but Prices Paid at 73 and the Highest Backlogs Since 2022 Signal More Inflation Ahead

Recommended For You

Wayfair Posts Its Strongest Sales Growth Since the Pandemic as U.S. Revenue Jumps 11.4% and It Swings to a $62 Million Profit

by Team Lumida
2 hours ago

Wayfair revenue rose 9.7% to $3.42 billion with US sales up 11.4%, its strongest growth since the pandemic, as it swung to a $62 million profit.

Read more

SpaceX Taps Qualcomm for Its Largest-Ever 5G Deal to Build Starlink Mobile’s U.S. Network, Stepping Up Its Challenge to Verizon, AT&T and T-Mobile

by Team Lumida
2 hours ago
Qualcomm Wins Crucial Legal Battle Against Arm Over Nuvia License Dispute

SpaceX signed a multiyear deal with Qualcomm to build base stations for Starlink Mobile, Qualcomm’s largest 5G initiative, as it targets US carriers.

Read more

Kraft Heinz Sells Maxwell House Coffee Unit at a $650 Million Valuation and Lifts Its Sales and EPS Outlook, Sending Shares Up 3%

by Team Lumida
2 hours ago

Kraft Heinz will divest its North American coffee unit at a $650 million valuation to One Rock and raised its 2026 outlook; shares rose 3% premarket.

Read more

Uber Tops Revenue Estimates at $14.77 Billion on a 34% Freight Surge, but Ride-Hailing and Delivery Both Miss as Fuel Costs Squeeze Drivers

by Team Lumida
2 hours ago

Uber beat Q3 revenue forecasts on a 34% jump in freight, but mobility revenue fell 2% and delivery missed as fuel costs and driver shortages hit.

Read more

McDonald’s Rises 5% as $3.57 EPS Tops Estimates and U.S. Same-Store Sales Dip Only 0.2%, Beating Fears of a Deeper Slide After Its Value Push

by Team Lumida
2 hours ago

McDonald’s shares rose about 5% as Q3 EPS of $3.57 beat estimates and US same-store sales fell only 0.2%, though revenue of $7.16 billion missed.

Read more

OPay Pulls Its $304 Million NYSE IPO After Pricing It, Citing a Foreign Regulatory Inquiry, in a Rare Last-Minute Cancellation for the US IPO Market

by Team Lumida
10 hours ago

SoftBank-backed OPay pulled its $304 million NYSE IPO after pricing it at $19, citing a foreign regulatory inquiry, a rare move in the US IPO market.

Read more

Booking Guides Fourth-Quarter Bookings Growth to Just 2%-4% vs 7% Expected, as Pricier Flights, Middle East Disruption and Paris Unrest Hit October Travel

by Team Lumida
10 hours ago

Booking expects 2% to 4% Q4 gross bookings growth, below the 7% analysts expected, after higher airfares and unrest hurt October travel demand.

Read more

3M Commits $7.35 Billion Over Nine Years to Settle Most of Up to 120,000 PFAS Injury Claims, With Just $50 Million Due This Year

by Team Lumida
10 hours ago

3M will pay $7.35 billion over nine years to settle most PFAS personal injury claims, paying $50 million this year and nothing in 2027.

Read more

Tesla and SpaceX Slip After Hours as the Blue Wave Threatens a ‘Double Whammy’ for Musk: Tighter AI Rules and a Slower Path for Their Merger

by Team Lumida
10 hours ago

Tesla and SpaceX fell about 1.8% after hours as a Democratic sweep raised the risk of tighter AI rules and a slower Tesla-SpaceX merger.

Read more

CVS Will Split in Two by Early 2028, Separating Aetna and Caremark From Its 9,000 Pharmacies and Unwinding the Merger That Defined Healthcare Gigantism

by Team Lumida
10 hours ago

CVS Health will split into two public companies by early 2028, putting Aetna and Caremark in one and its 9,000 retail pharmacies in the other.

Read more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

gas nozzle on car

LG Energy’s Profit Plunges: What This Means for the EV Market

July 8, 2024
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

The AI Cold War That Will Redefine Everything

November 11, 2025
a person writing on a piece of paper next to a computer monitor

Why Investors Are Flocking to Convertible Bonds: The Smart Bet on Small-Cap Stocks

July 27, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018